The spread of COVID-19 (coronavirus disease 19) has become global. Most of the medications being tested as potential treatments have not been subjected to rigorous scientific scrutiny in the form of randomized controlled trials. The need of the moment is to review the available data on the effectiveness of these medications against SARS-CoV-2 and related viruses (SARS and Middle East Respiratory Syndrome) in vitro and in vivo, and to assess their potential for re-purposing in the treatment of COVID-19. Ivermectine is one of them.
Dr. Papa Rao Nadakuduru
Practices at KIMS Hospital in Kondapur, Hyderabad and Icon Hospitals in Kukatpally, Hyderabad
Dr. Benny PV
Professor & HOD Department of Community Medicine & Staff Advisor in Sree Gokulam Medical-College
Dr. Surya Kant Tripathi
Prof & Head - Dept of Respiratory Medicine. KGMU. Lucknow Vice-Chairman IMA-AMS Past President ICS. NCCP and ICAAI
Dr. KK Aggarwal
President Heart Care Foundation of India and Group Editor in Chief MEDtalks
